TickerFacts.

Summit Therapeutics Inc. (SMMT): Weighted Average Diluted Shares

Annual figures by period end, from SEC filings.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2021-12-31 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

747.70M
Year ended 2025-12-31
+57.0%
3-year compound annual growth
2019-01-31: 17.23M2020-12-31: 69.52M2021-12-31: 131.71M2022-12-31: 193.34M2023-12-31: 619.65M2024-12-31: 718.54M2025-12-31: 747.70M747.70M
2019-01-31 Weighted Average Diluted Shares (shares) 2025-12-31
Period endedWeighted Average Diluted SharesChange YoYSource filing
2025-12-31747.70M+4.1%2026-02-23, From 2025-01-01
2024-12-31718.54M+16.0%2026-02-23, From 2024-01-01
2023-12-31619.65M+220.5%2026-02-23, From 2023-01-01
2022-12-31193.34Mn/c2025-02-24, From 2022-01-01
2021-12-31131.71Mn/c2023-03-09, From 2021-01-01
2020-12-3169.52Mn/c2022-12-21, From 2020-01-01
No annual figure between 2019-01-31 and 2020-12-31.
2019-01-3117.23Mn/a2021-03-31, From 2018-02-01